We would love to hear your thoughts about our site and services, please take our survey here.
I also requested the report from ii. Still no reply from them.
Recent Notable Cancer Research Discoveries: Advancements in Clinical ResearchHome Blog Main Recent Notable Cancer Research Discoveries: Advancements in Clinical Research
Recent Notable Cancer Research Discoveries: Advancements in Clinical Research
Recent Notable Cancer Research Discoveries: Advancements in Clinical Research
Keeping up with the latest cancer research discoveries is crucial for individuals interested in clinical advancements and treatment breakthroughs. In recent years, there have been remarkable developments in the field of cancer research, leading to improved diagnostic techniques, targeted therapies, and innovative treatment approaches. This blog highlights four notable discoveries from the past few years that have the potential to transform cancer care. These findings cover a range of cancer types and shed light on novel strategies for diagnosis, treatment, and prevention.
Liquid Biopsies:
Revolutionizing Cancer Diagnosis and Monitoring Liquid biopsies, a non-invasive approach to detect tumor-related genetic alterations in body fluids, have emerged as a promising tool for cancer diagnosis and monitoring. Recent research has demonstrated their effectiveness in detecting early-stage cancers, monitoring treatment response, and tracking the development of resistance (Wan et al., 2020). Liquid biopsies offer a less invasive alternative to traditional tissue biopsies and hold the potential to enable earlier detection and personalized treatment decisions.
Immunotherapy:
Enhancing the Body's Natural Defense Against Cancer Immunotherapy has revolutionized cancer treatment by harnessing the power of the immune system to target and eliminate cancer cells. Notable advancements include the development of immune checkpoint inhibitors, such as pembrolizumab (Keytruda) and nivolumab (Opdivo), which have shown remarkable success in treating a range of cancers, including melanoma, lung cancer, and bladder cancer (Gadgeel et al., 2019). These therapies work by releasing the brakes on the immune system, allowing it to recognize and attack cancer cells. Immunotherapy has significantly improved patient outcomes and offers new hope for those with advanced or refractory cancers.
Precision Medicine:
Tailoring Treatment to Genetic Alterations Precision medicine utilizes genomic profiling to identify specific genetic alterations in individual tumors and match patients with targeted therapies. The discovery of gene mutations, such as EGFR in non-small cell lung cancer, has led to the development of targeted therapies like osimertinib (Tagrisso) (Oxnard et al., 2018). Precision medicine has also shown promising results in other cancers, including breast, colorectal, and hematologic malignancies. By tailoring treatment to the genetic characteristics of each patient's tumor, precision medicine aims to improve treatment response rates and minimize side effects.
CAR-T Cell Therapy:
Revolutionizing Immunotherapy for Bloo
So sad to hear your tragic news. My heart bleeds for you. Can't think of anything worse that can happen to someone. You are in my thoughts and prayers.
Be nice if there are funds left over and we could use them to send food parcels to those ex Frontera workers who are struggling having lost their jobs. If we could also get some news coverage on this it could draw attention that there are shareholders also involved in this company. Anyone’s thoughts on this idea.
Check out IMM. Could be us one of these days.
Hi DPExplorer, Also so sorry to hear about the hard times you and your wife have been through this past year. I hope 2019 will be much kinder to you and happier times lie ahead. Best wishes to you both.
President Donald Trump barreled into a NATO summit Wednesday with claims that a natural gas pipeline deal has left Germany “totally controlled” and “captive to Russia” as he lobbed fresh complaints about allies’ “delinquent” defense spending during the opening of what was expected to be a fraught two-day meeting.
Trump also suggested that NATO allies commit to spending 4 percent of their gross domestic product on defense — double the current goal of 2 percent by 2024.
The president, in a testy exchange with NATO Secretary-General Jens Stoltenberg that kicked off his visit, took issue with the U.S. protecting Germany as it strikes deals with Russia.
“I have to say, I think it’s very sad when Germany makes a massive oil and gas deal with Russia where we’re supposed to be guarding against Russia,” Trump said at a breakfast with Stoltenberg. “We’re supposed to protect you against Russia but they’re paying billions of dollars to Russia and I think that’s very inappropriate.”
Trump repeatedly described Germany as “captive to Russia” because of the energy deal and urged NATO to look into the issue.
MoneyMap_Chicks_728x250RWE_Pot_FDA ApprovedMoneyMap_Chicks_728x250RWE_Pot_FDA Approved
German Chancellor Angela Merkel pushed back firmly, insisting that Germany makes its own decisions and drawing on her own background growing up in communist East Germany behind the Iron Curtain.
“I’ve experienced myself a part of Germany controlled by the Soviet Union and I’m very happy today that we are united in freedom as the Federal Republic of Germany and can thus say that we can determine our own policies and make our own decisions and that’s very good,” she said.
The president appeared to be referring to the Nord Stream 2 pipeline that would bring gas from Russia to Germany’s northeastern Baltic coast, bypassing Eastern European nations like Poland and Ukraine and doubling the amount of gas Russia can send directly to Germany. The vast undersea pipeline is opposed by the U.S. and some other EU members, who warn it could give Moscow greater leverage over Western Europe. It’s expected to be online at the end of 2019
In their back-and-forth, Stoltenberg stressed to Trump that NATO members have been able to work together despite their differences. “I think that two world wars and the Cold War taught us that we are stronger together than apart,” he told the president, trying to calm tensions.
Trump’s dramatic exchange with Stoltenberg set the tone for what was already expected to be a tense day of meetings with leaders of the military alliance as Trump presses jittery NATO allies about their military spending ahead of his meeting next week with Putin.
“The United States is paying far too much and other countries are not paying enough, especially some. So we’re going to have a meeting on that,” Trump said, describing the situation as “disproportionate and not fair to the taxpayers of the United States.”
“They will spend more,” he later pre
Thank you for explaining the difference between Volition's cancer tests and Angle's Parsortix. Puts my mind at rest as I was starting to get worried about competition.
I have just watched a video on Volition talking about their colo-rectal clinical trials using blood samples and that they hope to branch out to test other cancers. Does anyone know if they are they in competitiion with Angle?
Correct me if I am wrong but my understanding is that this share will only truly shine when the price of gold really takes off in a big way. Apparently gold miners always lag behind such a gold price rise as it takes a while to filter through to have an effect on the mine's profits. When it does happen though then the effect on the share price is dramatic and much greater than the rise in the gold price as little miners like Shanta will be so cash rich that we should all be more than happy with the share price. I am keeping an eye on the US Dollar Index which is currently at 94.13 and has fallen sharply from around 99.00 a few weeks ago. The one tipster I follow says that if it falls below 92.50 it will start a rush out of the dollar where everyone has been flocking to as a safe haven. He reckons that if that happens then gold will come into its own and we should see the start of the next bull run. Let's hope he is right and we will then be very happy with our holding here. I think Shanta is a little gold mine (excuse the pun) and I don't worry about the day to day share price as I feel confident it will shine brightly in the future.
I see Andrew Newland will be doing a presentation at the Master Investor Show in London on 23 April. He certainly is doing a good job on promoting the company. It obviously will take time for Parsortix to really take off in a big way what with waiting for FDA approvals and clinical trials etc. As the famous Warren Buffett said "The stock market is a device for transferrinfg money from the impatient to the patient." It certainly applies here and hopefully all us patient shareholders will all be suitably rewarded in the end.